Serum inhibin B concentrations in pubertal boys conceived by ICSI: first results
Authors: Belva, F.; Bonduelle, M.; Painter, R.C.; Schiettecatte, J.; Devroey, P.; De Schepper, J.
Source: Human Reproduction, Volume 25, Number 11, 16 November 2010 , pp. 2811-2814(4)
Publisher: Oxford University Press
Currently, no published data exist about the gonadal function of children born after ICSI. To evaluate potential risk of testicular seminal dysfunction in boys born to fathers with compromised spermatogenesis, serum inhibin B (as a marker for spermatogenesis) was assessed.
We recruited 50 pubertal adolescents from the oldest cohort of infants born following ICSI. Cross-sectional serum inhibin B levels of all 50 ICSI adolescents, and longitudinal serum inhibin B (assessed at 8 and 14 years) in 25 boys, are reported.
A statistically significant increase in inhibin B levels was observed between 8 (mean 69 ng/l, SD 35) and 14 years (mean 145 ng/l, SD 41; P < 0.001). In three quarters of the ICSI boys an increase in serum inhibin B levels of at least 30 between 8 and 14 years was observed. In all but 4 of the 14-year-old ICSI boys serum inhibin B was normal. Serum inhibin B levels in boys from fathers with severe oligozoospermia did not differ from concentrations in boys from fathers without severe oligozoospermia (154 51 and 142 47 ng/l, respectively; P 0.4).
The majority of ICSI boys have a significant increase in serum inhibin B, attaining normal values for pubertal status at the age of 14 years. ICSI adolescents from fathers with severely compromised spermatogenesis do not have lower inhibin B levels than those with fathers with normal spermatograms. Further follow-up of the spermatogenic potential of ICSI teenagers up to young adulthood is mandatory to confirm a normal reproductive capacity.
Document Type: Research Article
Publication date: 2010-11-16
- Human Reproduction features full-length, peer-reviewed papers reporting original research, clinical case histories, as well as opinions and debates on topical issues. Papers published cover the scientific and medical aspects of reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues. The highest scientific and editorial standard is maintained throughout the journal along with a rapid rate of publication.